Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Karen Hübscher

Dr. Karen Huebscher

Chairwoman of the Audit Committee
Since 2012, elected until 2020
1963, Swiss and British citizen

Education (IMD, Lausanne), Ph.D. Natural Sciences Molecular Biology (ETH Zurich), Masters Degree, Animal Sciences (ETH Zurich)
Professional background
Since 2014 CEO Solvias AG
Since 2012 Founder and Managing Director of Fibula Medical AG
2009 - 2011 Member of the European Commercial Operations Leadership Team and Site Head Novartis Vaccines & Diagnostics, Basel; Head Public Health and Market Access Europe (Marketing & Sales); Board member European Vaccines Manufacturer's Association, Brussels.
2006 - 2009 Member of the Global Executive Committee and Global Innovation Board, Novartis Vaccines & Diagnostics, with headquarters in the U.S., in charge of Business Development/Mergers and Acquisitions
2000 - 2005 Various positions with increasing responsibility in Research and Finance at CIBA Geigy and Novartis
1995 - 2000 Various positions
Other activities
SMG (Swiss Management Association), member of the board